 |
David M. Hall, BA, BComm
|
Mr. David Hall was previously with Angiotech Pharmaceuticals Inc. as Chief Compliance Officer, Senior Vice President of Government & Community Relations and acted as the Corporate Secretary and Treasurer of the company. He was responsible for Angiotech's overall governance and financial compliance, and acted as a key liaison to government and community agencies. Mr. Hall has been an integral part of many of the company's financial and corporate achievements while previously serving as Chief Financial Officer, which include its Initial Public Offering in 1997, listings on the NASDAQ and TSX stock exchanges, and seven successful equity financings. Experience in corporate finance, business and securities research provided a sound background to Mr. Hall’s position at Angiotech.
Prior to Angiotech, he was the Corporate Development Officer for ID Biomedical Corporation, an institutional research analyst and corporate financier for a national institutional brokerage company, and an equity portfolio manager for a large Canadian insurance company.
Mr. Hall is highly committed to governmental policy issues related to the biotech industry. He currently serves as past Chairman of the BC Biotech Association and as a Director of the International Finance Centre. He has sat as the Chairman of the Biotech Industry Advisory Committee to the BC Competition Council and as a member of the BC Task Force on PharmaCare. Mr. Hall is also a member of the University of British Columbia’s Tech Equity Investment Committee.
Mr. Hall received his BA in Economics (Honours) in 1975 and BComm in Finance (Honours) from the University of Manitoba in 1977.